-
Auranofin and Metabolic Stress in HCC Research
2026-09-15
Auranofin is a thioredoxin reductase inhibitor that can help researchers interrogate the relationship between redox control and metabolic plasticity in hepatocellular carcinoma. This article translates recent FOXO3/YAP findings into a rigorous, redox-aware assay strategy without overstating unvalidated mechanisms.
-
CHIR-99021 for Stem Cell and Organoid Workflows
2026-09-15
CHIR-99021 (CT99021) provides reversible, selective GSK-3α/β control for tuning pluripotency, endodermal patterning, and organoid maturation. This guide translates atlas-based developmental benchmarking into practical dosing, assay design, and troubleshooting strategies.
-
CCG-1423: A Pathway-Resolved Assay Strategy
2026-09-14
CCG-1423 is a RhoA inhibitor that helps separate MRTF-A transcriptional signaling from ROCK-dependent cytoskeletal remodeling. This article translates recent RhoA/ROCK pathway findings into a practical, evidence-aware framework for cancer research, apoptosis assay design, and cross-domain interpretation.
-
BAX–BAK Mosaic Rings in Apoptotic Mitochondria
2026-09-14
The reference study uses live- and fixed-cell STED microscopy to show that endogenous BAX and BAK assemble into heterogeneous mosaic rings on apoptotic mitochondria, rather than a uniform oligomeric structure. Its findings place BAK recruitment slightly ahead of BAX and show why endogenous protein measurements are essential for interpreting mitochondrial outer membrane permeabilization.
-
Aging Lens Epithelium and Ferroptosis Susceptibility
2026-09-13
Wei and colleagues show that aging lens epithelial cells become unusually vulnerable to ferroptosis, linking age-related redox imbalance, lipid peroxidation, iron accumulation, and impaired glutathione protection. Their combination of human and mouse models, glutathione perturbation, RSL3 and erastin exposure, and transcriptome analysis provides a mechanistic framework for studying ferroptosis in cataractogenesis.
-
WEHI-539: A BCL-XL Inhibitor Workflow
2026-09-12
WEHI-539 is a selective BCL-XL inhibitor for separating BCL-XL dependence from broader apoptotic stress. This practical guide connects dose-response testing, mitochondrial apoptosis assays, cancer stem cell sensitization, and MCL-1-focused combination studies.
-
1-methyl Adenosine Assay Workflows
2026-09-11
Build reliable 1-methyl Adenosine workflows for cell perturbation, intracellular nucleoside profiling, and biomarker discovery. The practical strategy combines controlled dosing with stable isotope-diluted UHPLC–MS/MS, chromatographic isomer separation, and matrix cleanup.
-
MK-571 Workflows for Inflammation Research
2026-09-11
MK-571 (L-660,711) helps separate cysteinyl leukotriene signaling from ABCC1/MRP1-linked drug transport in airway and macrophage assays. This practical guide covers assay setup, dosing logic, cross-model controls, and troubleshooting for bronchoconstriction, allergic inflammation, and chemotherapy-stress workflows.
-
RSL3 Workflows for GPX4-Driven Ferroptosis
2026-09-10
RSL3 provides a fast, mechanistically focused way to test GPX4-dependent ferroptosis, from HCC pathway studies to RAS-driven cancer models. This guide combines practical handling, quantitative assay conditions, TEAD2-informed experimental design, and troubleshooting for more reproducible oxidative cell-death results.
-
Schizophrenia Risk Pathways in Developing Neurons
2026-09-10
Liu et al. used cell-type-resolved human iPSC models to show that schizophrenia-associated loci converge on different developmental pathways in cortical interneurons and glutamatergic neurons. The study links interneuron risk loci to PKC hyperactivity and arborization defects, while glutamatergic-neuron loci affect ion transport and calcium currents, providing a framework for cell-specific mechanistic studies.
-
Amiloride (MK-870) for Ion Transport Workflows
2026-09-09
Amiloride (MK-870) enables controlled perturbation of epithelial sodium transport, with practical value in sodium channel research, cystic fibrosis research, and hypertension research. Its negative result in a reovirus-entry study also makes it a useful specificity control when testing cellular endocytosis modulation rather than a presumed universal uptake inhibitor.
-
SM-164: Reliable Apoptosis Assay Workflows
2026-09-09
This scenario-based guide explains how SM-164 (SKU A8815), a bivalent Smac mimetic, can support interpretable viability, proliferation, and apoptosis experiments. It covers mechanism, solvent compatibility, handling, orthogonal readouts, and practical criteria for selecting a reliable research reagent.
-
Sinapine Targets PLCβ3 EF Hands in Cardiovascular Disease
2026-09-08
The reference study identifies the PLCβ3 EF-hand domain, particularly Asn-260, as a druggable site for disrupting the Gαq–PLCβ3 interaction in RAAS-driven cardiovascular disease. By combining chemical-probe target identification, biochemical validation, and aldosteronism and hypertension models, the authors position sinapine as a more pathway-focused alternative to broad Gαq or PLC inhibition.
-
Primidone (Mysoline) for TRPM3 and RIPK1 Research
2026-09-08
Primidone, also known as Mysoline, gives researchers a practical bridge between TRPM3 channel pharmacology, RIPK1 signaling, and translational disease models. This guide covers assay setup, concentration selection, animal-study context, CYP19 counter-screening, and troubleshooting for reproducible workflows.
-
Silymarin: Silybin A Workflow for Liver Research
2026-09-07
Build reproducible Silybin A experiments around solubility control, orthogonal viability and motility assays, and pathway-aware validation. This workflow distinguishes purified Silybin A from Silymarin mixtures while adapting a hepatocellular carcinoma metastasis assay framework without overstating evidence.